MRNA vs AAPL: Which Stock is Better?
Side-by-side comparison of Moderna Inc and Apple Inc in 2026
MRNA
Moderna Inc
$53.57
AAPL
Apple Inc
$264.55
Key Metrics Comparison
| Metric | MRNA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $20.93B | N/A | MRNA |
| P/E Ratio | N/A | 33.85 | AAPL |
| EPS (TTM) | $N/A | $7.55 | AAPL |
| Revenue Growth | -0.3% | 6.4% | AAPL |
| Gross Margin | -105.8% | 46.9% | AAPL |
Analyze MRNA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MRNA or AAPL a better investment?
Comparing MRNA and AAPL: Moderna Inc has a market cap of $20.93B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MRNA and AAPL?
MRNA (Moderna Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MRNA or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MRNA or AAPL?
AAPL has higher revenue growth at 6.4% vs -0.3% for MRNA.
Which company is more profitable: MRNA or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to -105.8% for MRNA.
Which is the larger company: MRNA or AAPL?
Moderna Inc (MRNA) is larger with a market cap of $20.93B compared to N/A for AAPL.
Should I buy MRNA or AAPL in 2026?
Both MRNA and AAPL have investment merit. MRNA trades at $53.57 while AAPL trades at $264.55. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MRNA and AAPL stock?
Key differences: Market Cap ($20.93B vs N/A), P/E Ratio (N/A vs 33.8x), Revenue Growth (-0.3% vs 6.4%), Gross Margin (-105.8% vs 46.9%).